产品号: C300-005

批号: 63179

产品详情:

The recombinant Vesicular Stomatitis Virus (rVSV-ΔG) reverse genetics pseudotype system is widely used to generate rVSV particles that express the surface glycoprotein protein of a heterologous virus. This is a particularly powerful tool to study viruses that require high level biosafety containment (BSL-3 and BSL-4) such as Coronaviruses and Filoviruses1,2, as it generates virus that is restricted to a single round of replication, making them BSL-2 level compatible. This virus is pseudotyped with the S glycoprotein of SARS-CoV-2 (alpha) and contains a 16 amino acid deletion in the C-terminus.

产品类别: Virus

血清型: VSV Indiana / SARS-CoV-2 (Alpha)

相似产品名称: SARS-CoV-2 virus, SARS-CoV-2-VSV, SARS-CoV-2 virus, SARS-CoV-2 pseudotype, rVSV-SARS-CoV-2, COVID-19 virus, COVID-19 pseudovirus, COVID-19 pseudotype, 2019-nCoV, 2019-nCoV pseudotype virus, U.K. variant, Alpha variant, B.1.1.7

生物安全等级: BSL-2

应用: Screening antibodies or drugs for anti-SARS-CoV-2 neutralization activity, monitoring SARS-CoV-2 entry into target cells. Comparing the potency of different antiviral compounds to neutralize SARS-CoV-2 variants.

滴度: Will be provided with packing list

包装尺寸: A single vial can be used for 96 reactions. Please contact services@eliteimmune.com for protocol.

存储条件: -80°C. Multiple freeze thaw cycles will reduce titer.

运输条件: Dry Ice

目的用途: This product is for research use only. It is not intended for human, therapeutic, or diagnostic use. Buyer may not modify, sell, or transfer product for commercial use without written permission from Eliteimmune.

参考文献:

1.      Howell, K.A., et al., Cooperativity Enables Non-Neutralizing Antibodies to Neutralize Ebolavirus. Cell Reports, 2017. 19(2): p. 413-424.

2.     Whitt, M.A., Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J. Virol. Methods, 2010. 169(2): p. 365-74.

Alternative Names:

SARS-CoV-2 virus, SARS-CoV-2-VSV, SARS-CoV-2 virus, SARS-CoV-2 pseudotype, rVSV-SARS-CoV-2, COVID-19 virus, COVID-19 pseudovirus, COVID-19 pseudotype, 2019-nCoV, 2019-nCoV pseudotype virus, U.K. variant, Alpha variant, B.1.1.7